NCT06399419 2024-05-30CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerOsel, Inc.Phase 1 Recruiting28 enrolled
NCT01472081 2021-12-02Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)Bristol-Myers SquibbPhase 1 Completed194 enrolled 18 charts